- Home
- SYRE vs SPNT Comparison
SYRE vs SPNT Comparison
Compare SYRE & SPNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SYRE | SPNT |
|---|---|---|
| Founded | 2013 | 2011 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.3B |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | SYRE | SPNT |
|---|---|---|
| Price | $33.30 | $19.97 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 3 |
| Target Price | ★ $56.50 | $24.00 |
| AVG Volume (30 Days) | ★ 795.0K | 731.8K |
| Earning Date | 02-26-2026 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.45 |
| Revenue | N/A | ★ $2,859,100,000.00 |
| Revenue This Year | N/A | $0.89 |
| Revenue Next Year | N/A | $6.87 |
| P/E Ratio | ★ N/A | $13.76 |
| Revenue Growth | N/A | ★ 6.92 |
| 52 Week Low | $10.91 | $13.26 |
| 52 Week High | $35.31 | $22.89 |
Technical Indicators
Market Signals| Indicator | SYRE | SPNT |
|---|---|---|
| Relative Strength Index (RSI) | 58.08 | 38.01 |
| Support Level | $30.00 | $19.72 |
| Resistance Level | $34.21 | $20.59 |
| Average True Range (ATR) | 1.83 | 0.59 |
| MACD | -0.02 | -0.20 |
| Stochastic Oscillator | 84.46 | 9.38 |
Price Performance
Historical ComparisonAbout SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About SPNT SiriusPoint Ltd.
SiriusPoint Ltd provides property and casualty reinsurance coverage to insurance and reinsurance companies in the United States, Canada, Bermuda, the United Kingdom, and Europe. The company operates through two operating segments: Reinsurance and Insurance & Services. The company's product portfolio consists of reinsurance contracts for property insurance including both residential and commercial properties, workers' compensation, personal automobile, businesses' general liability insurance, professional liability insurance to protect professional advisors and service providers, agriculture insurance, and mortgage insurance. The majority of the revenue is generated from its Insurance & Services segment.